• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Personalised medicine - Articles and news items

personalised medicine

Researchers develop technology for printed personalised medicine

Industry news / 26 May 2016 / Victoria White, Digital Content Producer

Researchers from the National University of Singapore have found a way to make personalised medicine cheaper and easier…

peptide-vaccine

Personalised peptide vaccine increased bladder cancer survival in study

Industry news / 18 November 2015 / Victoria White

The median overall survival for patients assigned personalised peptide vaccine and best-supportive care was almost twice as long as that for patients assigned best-supportive care…

cyber-security-in-pharmaceuticals

Cyber security in pharmaceuticals

Blog / 22 October 2015 / Caroline Rivett and Dr Cornelius Namiluko at KPMG

Dr Cornelius Namiluko and Caroline Rivett discuss cyber security in the pharmaceutical industry and the approaches companies can take to address the risk of a cyber attack…

NGP Europe Summit

Can personalised medicine save the pharma sector?

Industry news, News / 17 March 2011 / GDS International

Personalised medicine is making a comeback – but will it stick this time?…

Personalised medicine: are we ready for the revolution?

Issue 2 2008, Past issues / 19 March 2008 /

The impact of biomarker technology and biomarker strategies in pharmaceutical development is still in its infancy; but the impact is already proving significant. Biomarker strategy forms the basis for personalised medicine, the industry/regulatory focus centres on improving the success rate and reducing the high attrition rate often encountered in early phases of clinical research. The depth and breadth of knowledge required to successfully implement biomarkers into drug development is generating company collaborations and inclusion of professionals that have not traditionally been part of drug product development.

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +